Works matching IS 21641153 AND DT 2014 AND VI 4 AND IP 4
Results: 7
Biomarker-Driven New Anticancer Drugs Reduce Toxicity and the Associated Costs.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 4, p. 11
- Publication type:
- Article
Molecular Profiling Not Cost-Effective for Adjuvant Chemotherapy Decision-Making in Patients with Node-Negative Breast Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 4, p. 10
- Publication type:
- Article
Pharmacy Practice Opportunities: Is This the Time for Change?
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 4, p. 19
- Publication type:
- Article
Hiccups.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 4, p. 15
- Publication type:
- Article
Panobinostat Improves Outcomes in Relapsed/Refractory Myeloma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 4, p. 12
- Publication type:
- Article
Prescribing of Low-Molecular-Weight Heparin and Warfarin in Patients with Acute Venous Thromboembolism and Active Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 4, p. 21
- Publication type:
- Article
Assessment of Patients' Knowledge and Management of Chemotherapy- Related Adverse Effects.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 4, p. 1
- Publication type:
- Article